U.S. Government Will Revive 1990s-Era Childhood Vaccine Safety Task Force
The U.S. Department of Health and Human Services (DHHS) announced on Aug. 14, 2025 that it would be reviving a Task Force on Safer Childhood Vaccines that was created under the National Childhood Vaccine Injury Act of 1986 but was disbanded in 1998. The task force was “a federal panel created by Congress to improve […]
FDA Revokes EUA Status for COVID-19 Shots
The U.S. Department of Health and Human Services (DHHS) has revoked emergency use authorization (EUA) for the COVID-19 shots. The federal government had relied on the EUA status to justify release of the COVID-19 biologicals in December 2020 for public distribution without full licensure by the FDA.1 On Aug. 27, 2025, DHHS Secretary Robert F. […]
DHHS Cancels $500 Million in Funding for mRNA Vaccine Development
Department of Health and Human Services (DHHS) Secretary Robert F. Kennedy, Jr. announced on Aug. 5, 2025 that DHHS is canceling $500 million in vaccine development projects, specifically those using mRNA technology. The decision affects 22 projects, including contracts with Emory University and Tiba Biotech. Proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others […]
Pfizer’s COVID-19 Shot Linked to Serious Damage to Eyes
A new peer-reviewed study out of Turkey has found that the Pfizer/BioNTech mRNA COVID-19 biologic (Comirnaty) may cause significant and measurable changes to eye health that, for some individuals, could contribute to long-term or even permanent vision complications. The study, published in Ophthalmic Epidemiology on July 14, 2025 tracked 64 patients over a 2.5-month period, […]
ACIP Majority Ignores Risks and Recommends Infants Get Merck’s RSV Monoclonal Antibody
On June 25, 2025, the majority of members of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ignored risk warnings and voted for a recommendation that infants be given Merck & Co.’s monoclonal antibody, clesrovimab, marketed as Enflonsia. The committee advised using Enflonsia to prevent Respiratory Syncytial Virus […]
Push for National Bird Flu Vaccine Program as USDA Points to Falling Egg Prices After Gains in Biosecurity Containment
Publicity about avian influenza (H5N1) infecting chickens, turkeys and cows in the United States1 and globally has been widespread for several years as fears about the possibility of bird flu epidemics among humans have led to calls for acceleration of development and use of animal and human bird flu vaccines.2 3 4 5 In February […]